Iovance Biotherapeutics Inc (IOVA)

[GMH*]

I had noted that comment on why people were disqualified from treatment and discussion around not within label including "not having melanoma". I really do not think there will be off-label use just because payers have to authorize so the price tag will probably eliminate off-label unless someone pays cash or if NCCN recommends off-label (which I would doubt will happen). I would think that these individuals would look for a TIL clinical trial as an alternative.